Skip to content

Examining the Feasibility of Implementing a Hypertension Storytelling Intervention Among African Americans

Examining the Feasibility of Implementing a Hypertension Storytelling Intervention Among African Americans With Hypertension

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07071077
Enrollment
60
Registered
2025-07-17
Start date
2025-01-29
Completion date
2026-05-31
Last updated
2025-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

Medication Adherence, Lifestyle Intervention, Behavioral Change

Brief summary

The purpose of this study is to assess if storytelling is an effective approach for promoting lifestyle and behavioral change among individuals managing hypertension and to determine if storytelling interventions can help to reduce blood pressure and improve medication adherence.

Interventions

BEHAVIORALWeb-Based Storytelling Intervention

The Web-based storytelling group will access stories and educational materials on the study website.

BEHAVIORALGroup-Based Storytelling Plus Intervention

The storytelling plus group will watch the stories in a group setting, share their experiences and have educational sessions led by a health coach.

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
University of Delaware
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* African American/Black * Diagnosed with Hypertension * Prescribed medication for hypertension

Exclusion criteria

* Cognitive limitations that limit the ability to provide informed consent * Pregnancy * Unable to speak or read English * Planning to relocate during the study period

Design outcomes

Primary

MeasureTime frameDescription
Systolic and Diastolic Blood Pressure6 monthsBlood pressure will be measured three times using a manual blood pressure monitor.
Adherence to Antihypertensive Medications (daily usage)6 monthsMedication adherence will be measured using Medication Electronic Measuring System (MEMS) caps
Adherence to Antihypertensive Medications (self reported)6 monthsMedication adherence will be measure through participant self report Domains of Subjective Extent of Nonadherence scale.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026